Last reviewed:September 2019
Last updated:May  2019

Summary

Definition

History and exam

Key diagnostic factors

  • variable onset
  • pink, red, or blue color
  • rapid growth
  • variable compressibility
  • flat or nodular character

Other diagnostic factors

  • islands of normal skin
  • ulceration and bleeding
  • warmth
  • history of low birth weight
  • variable pain
  • associated defects
  • beard distribution and stridor
  • lumbosacral location
  • multiple lesions
  • poor infantile feeding, failure to gain weight
  • high-output cardiac failure

Risk factors

  • low birth weight
  • birth prematurity
  • white ethnicity
  • female sex
  • maternal multiple gestation
  • advanced maternal age
  • chorionic villus sampling

Diagnostic investigations

1st investigations to order

  • Doppler ultrasound of hemangioma
Full details

Investigations to consider

  • MRI of hemangioma
  • biopsy of lesion
Full details

Treatment algorithm

Contributors

Associate Professor of Dermatology & Child Health

Pediatric Dermatology

University of Missouri – Columbia

Columbia

MO

Disclosures

KLM is an investigator in clinical trials with Scioderm, Lilly, and Durata; payments were received by her institution for these trials. None of these are relevant to this topic.

Dr Kari L. Martin would like to gratefully acknowledge Dr Tobian Muir, Dr Ingrid Polcari, Dr Annette Wagner, and Dr Carla T. Lee, the previous contributors to this topic. TM, IP, and CTL declare that they have no competing interests. AW: none disclosed.

Peer reviewersVIEW ALL

Head

Department of Dermatology

The Hospital for Sick Children

Toronto

Ontario

Canada

Disclosures

EP is an author of a number of references cited in this topic.

Consultant Dermatologist

King's College Hospital

London

UK

Disclosures

EH declares that she has no competing interests.

Professor of Clinical Dermatology and Pediatrics

University of California San Francisco

San Francisco

CA

Disclosures

IF is a consultant for Pierre Fabre Dermatology, which is involved in clinical trials of propranolol for hemangiomas. IF is an author of a number of references cited in this topic.

Use of this content is subject to our disclaimer